CytoTronics has filed a notice of an exempt offering of securities to raise $13,500,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, CytoTronics is raising up to $13,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Jeffrey Abbott played a key…